- Home
- ITOS vs TCI Comparison
ITOS vs TCI Comparison
Compare ITOS & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- TCI
- Stock Information
- Founded
- ITOS 2011
- TCI 1983
- Country
- ITOS United States
- TCI United States
- Employees
- ITOS N/A
- TCI N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- TCI Real Estate
- Sector
- ITOS Health Care
- TCI Finance
- Exchange
- ITOS Nasdaq
- TCI Nasdaq
- Market Cap
- ITOS 270.7M
- TCI 248.2M
- IPO Year
- ITOS 2020
- TCI N/A
- Fundamental
- Price
- ITOS $6.51
- TCI $28.23
- Analyst Decision
- ITOS Strong Buy
- TCI
- Analyst Count
- ITOS 3
- TCI 0
- Target Price
- ITOS $26.00
- TCI N/A
- AVG Volume (30 Days)
- ITOS 413.2K
- TCI 2.5K
- Earning Date
- ITOS 05-09-2025
- TCI 05-08-2025
- Dividend Yield
- ITOS N/A
- TCI N/A
- EPS Growth
- ITOS N/A
- TCI N/A
- EPS
- ITOS N/A
- TCI 0.68
- Revenue
- ITOS $35,000,000.00
- TCI $47,778,000.00
- Revenue This Year
- ITOS N/A
- TCI N/A
- Revenue Next Year
- ITOS $31.74
- TCI N/A
- P/E Ratio
- ITOS N/A
- TCI $41.60
- Revenue Growth
- ITOS 177.89
- TCI N/A
- 52 Week Low
- ITOS $4.80
- TCI $25.50
- 52 Week High
- ITOS $18.75
- TCI $32.30
- Technical
- Relative Strength Index (RSI)
- ITOS 55.62
- TCI 49.21
- Support Level
- ITOS $4.80
- TCI $27.83
- Resistance Level
- ITOS $5.55
- TCI $28.80
- Average True Range (ATR)
- ITOS 0.43
- TCI 0.63
- MACD
- ITOS 0.13
- TCI -0.04
- Stochastic Oscillator
- ITOS 97.16
- TCI 23.48
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About TCI Transcontinental Realty Investors Inc.
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.